FDA Vaccine Chief Overrules Scientists on Covid Shot Eligibility Sparks Backlash

Recent documents released by the Food and Drug Administration indicate a significant clash between agency leadership and its scientists regarding Covid vaccine accessibility. Staff members had recommended expanding eligibility for the vaccines to a wider age demographic due to concerning hospitalization rates for young children diagnosed with Covid-19. They argued that the unpredictable nature of the virus necessitated more inclusive access to the vaccines.

However, Dr. Vinay Prasad, who leads the FDA’s vaccine and gene therapy division, chose to reject these recommendations. He implemented stricter eligibility criteria, authorizing access to the Covid vaccines from Moderna and Pfizer only for individuals under the age of 65 who possess certain health conditions that heighten their risk for severe illness. This decision has ignited criticism from various stakeholders, including lawmakers, state officials, and medical practitioners who advocate for broader vaccination efforts.